Summit Trail Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.2K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $55K | Hold |
|
|||||
|
2024
Q2 | $45.2K | Hold |
|
|||||
|
2024
Q1 | $47.8K | Hold |
|
|||||
|
2023
Q4 | $33.2K | Hold |
|
|||||
|
2023
Q3 | $38.4K | Hold |
|
|||||
|
2023
Q2 | $28.8K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $39K | Hold |
|
|||||
|
2022
Q2 | $31K | Hold |
|
|||||
|
2022
Q1 | $38K | Buy |
|